Navigation Links
Halo Pharmaceutical Welcomes Al Rosenston as its Vice President, Business Development

WHIPPANY, N.J., Jan. 26 /PRNewswire/ -- Adding to its strong executive team, Halo Pharmaceutical today announced the addition of Allen M. Rosenston, a thirty-five year pharmaceutical industry veteran, as Halo's new Vice President of Business Development. Al comes to Halo from a long and distinguished career at Abbott Laboratories where he held diverse roles in operations, business development, and related business functions. "The addition of Al to the Halo business development team is a significant achievement. Al has deep experience within the pharmaceutical industry. He developed Abbott's domestic Contract Pharmaceutical Manufacturing Business Unit and, at the time of his retirement, he was responsible for the global finished goods contract manufacturing business," according to Mohd Asif, Halo's Chief Financial Officer.

Al comes to Halo shortly after Halo's acquisition of its Whippany, NJ facility, a facility which has been producing various dosage forms for 35 years. "I am thrilled to be part of the Halo Pharmaceutical team, and to build on the legacy of this outstanding facility and group of talented people with an average seniority of over 20 years. Based on my discussions with the new Halo team, this is a unique opportunity to create a world-class pharmaceutical services company right in the heart of New Jersey. Maintaining focus on quality, service, and compliance, along with the flexible manufacturing capabilities of the Whippany facility, will create a high-level of interest with prospective customers. I anticipate us to be highly competitive when overall service value is assessed."

Halo capabilities include an impressive array of formulation services, operations for the aseptic filling of topical ointments, solid dosage forms (tablets and capsules), liquids, suppositories, associated packaging (tablet, powder, liquids and HUD) and ample laboratory space for formulation development, pre-clinical and clinical supplies and support of commercial operations. An additional asset is the site's capability to manufacture controlled substances (C2-C5) and an API manufacturing unit with an outstanding track-record of meeting DEA requirements.

Al joined Halo on January 5, 2009, and can be reached at or at 973-428-4087.

About Halo Pharmaceutical

Halo Pharmaceutical, headquartered in Whippany, NJ, is a full-service, specialty pharmaceutical company, offering state-of-the-art contract manufacturing, early stage formulation development and laboratory services to the pharmaceutical and related industries. Halo is currently a supplier of choice to a number of large and medium size brand pharmaceutical companies for important lifecycle products. Contract manufacturing capabilities include the ability to conduct aseptic filling, granulation, blending, tableting, coating, packaging, and related warehousing operations. Halo Pharmaceutical is a privately-held company.

SOURCE Halo Pharmaceutical
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. KV Pharmaceutical Suspends Product Manufacturing, Shipping
2. KV Pharmaceuticals Launch of Gestiva(TM) Delayed
3. Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals
4. Caraco Pharmaceutical Laboratories, Ltd. to Announce Third Quarter of Fiscal Year 2009 Results on January 29, 2009
5. University Medical Pharmaceuticals Appoints Tom Roche as Senior Vice President, Global Sales and Marketing
6. Amylin Pharmaceuticals to Webcast Year-End Results
7. Renhuang Pharmaceuticals, Inc. Engages New Independent Auditor
8. Abbott Opens New Pharmaceutical Research Laboratory in Singapore
9. Law Firm Freedland Russo Spearheads Record-Setting Whistleblower Case Against Pharmaceutical Giant Eli Lilly -- Firm Expands Offices to Include L.A. Entertainment Branch
10. NUCRYST Pharmaceuticals appoints a new director
11. Peptimmune Grants Major Pharmaceutical Company Exclusive Option to License PI-2301 for Multiple Sclerosis
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... Physicians’ Education Resource®, LLC ... today announced that the first annual School of Gastrointestinal Oncology™ (SOGO™) will be ... and treatment of gastrointestinal cancers are undergoing transformational change, providing oncologists with powerful ...
(Date:12/1/2015)... ... 2015 , ... Growth in medical payments per workers’ compensation claim in Louisiana ... and nonhospital care, according to a recent study by the Workers Compensation Research Institute ... found medical payments per claim with more than seven days of lost time continued ...
(Date:12/1/2015)... Illinois (PRWEB) , ... December 01, 2015 , ... ... and share medical images have been lifted as IMAGE Information Systems launches MED-TAB™ ... Society of North America Annual Meeting from November 29 to December 4, 2015. ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... , Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. ... results enhancements at the Radiological Society of North America (RSNA) 2015 annual meeting ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... solutions for the care management and population health arenas, is pleased to announce ... and cost containment services, has successfully implemented the ACUITY Complete Care™ Management to ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Germany , December 1, 2015 /PRNewswire/ ... leading global manufacturer of eye and gaze tracking solutions, ... SMI remote eye trackers as a component of its ... concussions, eye sight, and medical and performance issues in ... part of SMI,s mass-market-ready eye tracking platform, which is ...
(Date:12/1/2015)... 1, 2015 --> ... van Leeuwenhoek Hospital (NKI-AVL), among the world,s largest ... Leksell Gamma Knife® Icon™, the company,s latest generation ... --> --> With the ... treatments, Leksell Gamma Knife Icon offers greatly enhanced ...
(Date:12/1/2015)... Dec. 01, 2015 ... "Drug Delivery Technology Market 2015 - Forecast ... --> ) has announced the addition ... - Forecast to 2020" report to their ... ) has announced the addition of the ...
Breaking Medicine Technology: